Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapy.
Hanaoka H, Nagaya T, Sato K, Nakamura Y, Watanabe R, Harada T, Gao W, Feng M, Phung Y, Kim I, Paik CH, Choyke PL, Ho M, Kobayashi H.
Hanaoka H, et al. Among authors: kobayashi h.
Mol Pharm. 2015 Jun 1;12(6):2151-7. doi: 10.1021/acs.molpharmaceut.5b00132. Epub 2015 May 19.
Mol Pharm. 2015.
PMID: 25955255
Free PMC article.